Cancer Biomarkers Market

Cancer Biomarkers Market Analysis by Test Type (PSA Tests CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, KRAS Mutation Tests), by Illness Indication (Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer), by Region - Global Insights 2022-2032

Analysis of Cancer Biomarkers market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Cancer Biomarkers Products Market Overview

    4.1. Introduction (Product Definition)

    4.2. Industry Evolution/Development

    4.3. Key Market Indicators

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity

    4.5. Global Cancer Biomarkers Market Analysis and Forecasts, 2022-2032

    4.6. Cancer Biomarkers Market - Global Supply Demand Scenario

    4.7. Porter’s Five Force Analysis

    4.8. Market Outlook

    4.9. Cancer Epidemiology, by region

5. Global Cancer Biomarkers Market Analysis and Forecast by Test Type

    5.1. Key Findings

    5.2. Introduction

    5.3. Market Size (US$ Mn) Forecast, By Test Type

        5.3.1. PSA Tests

        5.3.2. CTC Tests

        5.3.3. AFP Tests

        5.3.4. CA Tests

        5.3.5. HER2 Tests

        5.3.6. BRCA Tests

        5.3.7. ALK Tests

        5.3.8. CEA Tests

        5.3.9. EGFR Mutation Tests

        5.3.10. KRAS Mutation Tests

        5.3.11. Others

    5.4. Market Attractiveness, By Test Type

    5.5. Key Trends

6. Global Cancer Biomarkers Market Analysis and Forecast by Disease Indication

    6.1. Key Findings

    6.2. Introduction

    6.3. Market Size (US$ Mn) Forecast, By Disease Indication

        6.3.1. Breast Cancer

        6.3.2. Lung Cancer

        6.3.3. Colorectal Cancer

        6.3.4. Melanoma

        6.3.5. Blood Cancer

        6.3.6. Prostate Cancer

        6.3.7. Ovarian Cancer

        6.3.8. Stomach Cancer

        6.3.9. Liver Cancer

        6.3.10. Others

    6.4. Market Attractiveness, By Disease Indication

    6.5. Key Trends

7. Global Cancer Biomarkers Market Analysis and Forecast by Region

    7.1. Key Findings

    7.2. Introduction

        7.2.1. Market Size (US$ Mn) Forecast, By Region

        7.2.2. North America

        7.2.3. Europe

        7.2.4. Asia Pacific

        7.2.5. Latin America

        7.2.6. Middle East and Africa

8. North America Cancer Biomarkers Market Analysis and Forecast by Region

    8.1. Key Findings

    8.2. North America Cancer Biomarkers Market Forecast, by Test Type

    8.3. North America Cancer Biomarkers Market Forecast, by Disease Indication

    8.4. North America Cancer Biomarkers Market Forecast, by Country

        8.4.1. U.S. Cancer Biomarkers Market Overview

        8.4.2. Canada Cancer Biomarkers Market Overview

    8.5. North America Market Attractiveness Analysis

    8.6. Market Trends

9. Europe Cancer Biomarkers Market Analysis and Forecast by Region

    9.1. Key Findings

    9.2. Europe Cancer Biomarkers Market Forecast, by Test Type

    9.3. Europe Cancer Biomarkers Market Forecast, by Disease Indication

    9.4. Europe Cancer Biomarkers Market Forecast, by Country

        9.4.1. U.K. Cancer Biomarkers Market Overview

        9.4.2. Germany Cancer Biomarkers Market Overview

        9.4.3. France Cancer Biomarkers Market Overview

        9.4.4. Italy Cancer Biomarkers Market Overview

        9.4.5. Spain Cancer Biomarkers Market Overview

        9.4.6. Russia Cancer Biomarkers Market Overview

        9.4.7. Rest of Europe Cancer Biomarkers Market Overview

    9.5. Europe Market Attractiveness Analysis

    9.6. Market Trends

10. Asia Pacific Cancer Biomarkers Market Analysis and Forecast by Region

    10.1. Key Findings

    10.2. Asia Pacific Cancer Biomarkers Market Forecast, by Test Type

    10.3. Asia Pacific Cancer Biomarkers Market Forecast, by Disease Indication

    10.4. Asia Pacific Cancer Biomarkers Market Forecast, by Country

        10.4.1. India Cancer Biomarkers Market Overview

        10.4.2. China Cancer Biomarkers Market Overview

        10.4.3. Japan Cancer Biomarkers Market Overview

        10.4.4. Australia & New Zealand Cancer Biomarkers Market Overview

        10.4.5. Rest of APAC Cancer Biomarkers Market Overview

    10.5. Asia Pacific Market Attractiveness Analysis

    10.6. Market Trends

11. Latin America Cancer Biomarkers Market Analysis and Forecast by Region

    11.1. Key Findings

    11.2. Latin America Cancer Biomarkers Market Forecast, by Test Type

    11.3. Latin America Cancer Biomarkers Market Forecast, by Disease Indication

    11.4. Latin America Cancer Biomarkers Market Forecast, by Country

        11.4.1. Brazil Cancer Biomarkers Market Overview

        11.4.2. Mexico Cancer Biomarkers Market Overview

        11.4.3. Rest of LATAM Cancer Biomarkers Market Overview

    11.5. Latin America Market Attractiveness Analysis

    11.6. Market Trends

12. Middle East and Africa Cancer Biomarkers Market Analysis and Forecast by Region

    12.1. Key Findings

    12.2. Middle East and Africa Cancer Biomarkers Market Forecast, by Test Type

    12.3. Middle East and Africa Cancer Biomarkers Market Forecast, by Disease Indication

    12.4. Middle East and Africa Cancer Biomarkers Market Forecast, by Country

        12.4.1. South Africa Cancer Biomarkers Market Overview

        12.4.2. GCC countries Cancer Biomarkers Market Overview

        12.4.3. Rest of MEA Cancer Biomarkers Market Overview

    12.5. Middle East and Africa Market Attractiveness Analysis

    12.6. Market Trends

13. Competitive Landscape

    13.1. Market Share Analysis, by Company

    13.2. Competition Matrix

    13.3. Company Profiles

        13.3.1. Abbott Laboratories

            13.3.1.1. Company Details

            13.3.1.2. Business Overview

            13.3.1.3. Financial Overview

            13.3.1.4. Strategic Overview

            13.3.1.5. SWOT Analysis

        13.3.2. Merck & Co., Inc.

            13.3.2.1. Company Details

            13.3.2.2. Business Overview

            13.3.2.3. Financial Overview

            13.3.2.4. Strategic Overview

            13.3.2.5. SWOT Analysis

        13.3.3. Thermo Fisher Scientific Inc.

            13.3.3.1. Company Details

            13.3.3.2. Business Overview

            13.3.3.3. Financial Overview

            13.3.3.4. Strategic Overview

            13.3.3.5. SWOT Analysis

        13.3.4. Illumina, Inc.

            13.3.4.1. Company Details

            13.3.4.2. Business Overview

            13.3.4.3. Financial Overview

            13.3.4.4. Strategic Overview

            13.3.4.5. SWOT Analysis

        13.3.5. bioMérieux SA

            13.3.5.1. Company Details

            13.3.5.2. Business Overview

            13.3.5.3. Financial Overview

            13.3.5.4. Strategic Overview

            13.3.5.5. SWOT Analysis

        13.3.6. QIAGEN

            13.3.6.1. Company Details

            13.3.6.2. Business Overview

            13.3.6.3. Financial Overview

            13.3.6.4. Strategic Overview

            13.3.6.5. SWOT Analysis

        13.3.7. Agilent Technologies, Inc.

            13.3.7.1. Company Details

            13.3.7.2. Business Overview

            13.3.7.3. Financial Overview

            13.3.7.4. Strategic Overview

            13.3.7.5. SWOT Analysis

        13.3.8. Hologic, Inc.

            13.3.8.1. Company Details

            13.3.8.2. Business Overview

            13.3.8.3. Financial Overview

            13.3.8.4. Strategic Overview

            13.3.8.5. SWOT Analysis

        13.3.9. Novartis AG

            13.3.9.1. Company Details

            13.3.9.2. Business Overview

            13.3.9.3. Financial Overview

            13.3.9.4. Strategic Overview

            13.3.9.5. SWOT Analysis

        13.3.10. F. Hoffmann-La Roche Ltd.

            13.3.10.1. Company Details

            13.3.10.2. Business Overview

            13.3.10.3. Financial Overview

            13.3.10.4. Strategic Overview

            13.3.10.5. SWOT Analysis

        13.3.11. Genomic Health, Inc.

            13.3.11.1. Company Details

            13.3.11.2. Business Overview

            13.3.11.3. Financial Overview

            13.3.11.4. Strategic Overview

            13.3.11.5. SWOT Analysis

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032

Table 02: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032

Table 03: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Region Type, 2015-2032

Table 04: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032

Table 05: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032

Table 06: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032

Table 07: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032

Table 08: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032

Table 09: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032

Table 10: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032

Table 11: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032

Table 12: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032

Table 13: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032

Table 14: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032

Table 15: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032

Table 16: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032

Table 17: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032

Table 18: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032

Figure 02: Global Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032

Figure 03: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PSA Tests, 2022-2032

Figure 04: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CTC Tests, 2022-2032

Figure 05: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by AFP Tests, 2022-2032

Figure 06: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CA Tests, 2022-2032

Figure 07: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by HER2 Tests, 2022-2032

Figure 08: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by BRCA Tests, 2022-2032

Figure 09: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ALK Tests, 2022-2032

Figure 10: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CEA Tests, 2022-2032

Figure 11: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EGFR Tests, 2022-2032

Figure 12: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by KRAS Mutation Tests, 2022-2032

Figure 13: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022-2032

Figure 14: Cancer Biomarkers Market Attractiveness Analysis by Test Type

Figure 15: Global Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032

Figure 16: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2022-2032

Figure 17: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2022-2032

Figure 18: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2022-2032

Figure 19: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melanoma, 2022-2032

Figure 20: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Cancer, 2022-2032

Figure 21: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2022-2032

Figure 22: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ovarian Cancer, 2022-2032

Figure 23: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stomach Cancer, 2022-2032

Figure 24: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liver Cancer, 2022-2032

Figure 25: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022-2032

Figure 26: Cancer Biomarkers Market Attractiveness Analysis by Disease Indication

Figure 27: Global Cancer Biomarkers Market Value Share Analysis by Region Type, 2022 and 2032

Figure 28: Cancer Biomarkers Market Attractiveness Analysis, By Region Type

Figure 29: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032

Figure 30: North America Market Attractiveness Analysis by Country

Figure 31: North America Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032

Figure 32: North America Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032

Figure 33: North America Market Value Share Analysis by Country, 2022 and 2032

Figure 34: North America Market Attractiveness Analysis, By Test Type

Figure 35: North America Market Attractiveness Analysis, By Disease Indication

Figure 36: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032

Figure 37: Europe Market Attractiveness Analysis by Country

Figure 38: Europe Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032

Figure 39: Europe Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032

Figure 40: Europe Market Value Share Analysis by Country, 2022 and 2032

Figure 41: Europe Market Attractiveness Analysis, By Test Type

Figure 42: Europe Market Attractiveness Analysis, By Disease Indication

Figure 43: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032

Figure 44: Asia Pacific Market Attractiveness Analysis by Country

Figure 45: Asia Pacific Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032

Figure 46: Asia Pacific Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032

Figure 47: Europe Market Value Share Analysis by Country, 2022 and 2032

Figure 48: Asia Pacific Market Attractiveness Analysis, By Test Type

Figure 49: Asia Pacific Market Attractiveness Analysis, By Disease Indication

Figure 50: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032

Figure 51: Latin America Market Attractiveness Analysis by Country

Figure 52: Latin America Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032

Figure 53: Latin America Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032

Figure 54: Latin America Market Value Share Analysis by Country, 2022 and 2032

Figure 55: Latin America Market Attractiveness Analysis, By Test Type

Figure 56: Latin America Market Attractiveness Analysis, By Disease Indication

Figure 57: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032

Figure 58: Middle East & Africa Market Attractiveness Analysis by Country

Figure 59: Middle East & Africa Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032

Figure 60: Middle East & Africa Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032

Figure 61: Middle East & Africa Market Value Share Analysis by Country, 2022 and 2032

Figure 62: Middle East & Africa Market Attractiveness Analysis, By Test Type

Figure 63: Middle East & Africa Market Attractiveness Analysis, By Disease Indication

Figure 64: Global Cancer Biomarkers Market Share Analysis by Company (2022)

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Cancer Biomarkers Market

Schedule a Call